{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:05:29Z","timestamp":1771355129719,"version":"3.50.1"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>Introduction\u00a0: Le syndrome m\u00e9tabolique (SM) est responsable de l'augmentation du risque cardiovasculaire chez les patients pr\u00e9sentant un diab\u00e8te de type 2. Peu d'\u00e9tudes se sont int\u00e9ress\u00e9es au SM chez les diab\u00e9tiques de type 1 (DT1).\nObjectif\u00a0: D\u00e9crire les caract\u00e9ristiques cliniques, biochimiques et th\u00e9rapeutiques des DT1 atteints du SM.\nM\u00e9thodes\u00a0: Une \u00e9tude r\u00e9trospective a \u00e9t\u00e9 r\u00e9alis\u00e9e. Elle a inclus 36 patients, atteints de DT1 et de SM, hospitalis\u00e9s dans le Service d'Endocrinologie-Diab\u00e9tologie du CHU H\u00e9di Chaker de Sfax-Tunisie, de 1997 \u00e0 2020. Le SM a \u00e9t\u00e9 d\u00e9fini selon les crit\u00e8res NCEP-ATP III.\nR\u00e9sultats\u00a0: L'\u00e2ge moyen des patients \u00e9tait de 53 ans. La dur\u00e9e moyenne du diab\u00e8te \u00e9tait de 15 ans. Le SM est apparu apr\u00e8s une dur\u00e9e moyenne du diab\u00e8te de 13,7 ans. Une HTA a \u00e9t\u00e9 rapport\u00e9e chez 21 patients (58,3%). L'IMC moyen \u00e9tait de 26 kg\/m2. Le taux moyen de cholest\u00e9rol total \u00e9tait de 4,59 mmol\/l\u00b11,18, celui des triglyc\u00e9rides de 1,67 mmol\/l\u00b10,81. Le taux moyen d\u2019HDL-cholest\u00e9rol \u00e9tait de 0,96 mmol\/l\u00b10,29. Dans la majorit\u00e9 des cas (80%), le SM s'agissait de l'association d'une dyslipid\u00e9mie, d'une HTA et d'un diab\u00e8te. Sur le plan th\u00e9rapeutique, la dose moyenne d'insuline utilis\u00e9e \u00e9tait de 0,8 UI\/kg\/jour. L'association de metformine a \u00e9t\u00e9 n\u00e9cessaire dans 18 cas (50%). Les complications microvasculaires \u00e9taient pr\u00e9sentes chez tous les patients. Le risque cardiovasculaire \u00e9tait tr\u00e8s \u00e9lev\u00e9 chez tous les patients.\nConclusion\u00a0: La pr\u00e9valence du SM au cours du DT1 est en augmentation. Il indique un risque accru de complications micro et macrovasculaires.<\/jats:p>","DOI":"10.62438\/tunismed.v102i12.4916","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:47:04Z","timestamp":1737125224000},"source":"Crossref","is-referenced-by-count":1,"title":["Diab\u00e8te de Type 1 et Syndrome M\u00e9tabolique : Exploration d'une Relation Complexe"],"prefix":"10.62438","volume":"102","author":[{"given":"Dhoha","family":"Ben Salah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Elleuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddiqa","family":"Soomauroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khouloud","family":"Boujelben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten","family":"Hadjkacem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Mnif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Mnif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Rekik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31112","published-online":{"date-parts":[[2024,12,1]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:47:04Z","timestamp":1737125224000},"score":1,"resource":{"primary":{"URL":"https:\/\/latunisiemedicale.com\/index.php\/tunismed\/article\/view\/4916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v102i12.4916","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"value":"2724-7031","type":"electronic"},{"value":"0041-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}